Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Self-Funded
- Ownership
- Private
- Development stage
- Other
01
Overview
LifeArc is a self-funded medical research charity focused on advancing the translation of early scientific discoveries into healthcare treatments or diagnostics. It has extensive experience commercializing academic research and has contributed to the launch of 12 drugs, including the blockbuster immuno-oncology therapy Keytruda (pembrolizumab). The organization operates through collaborations with charities, academia, industry partners, and other stakeholders.
- Modalities
- Small moleculeMonoclonal antibodyBiologic
- Industry
- Academic Hospital/University/Research
02
Partnerships
Multiple global pharma and biotech companies via over 400 commercial licenses
Beyond the preview
Go deeper on Self-Funded.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Self-Funded.